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Abstract 
Objective: Part B of the Trail Making Test (TMT-B) is one of the most widely used 
neuropsychological tests of ‘executive’ function. A commonly held assumption is that 
the TMT-B can be used to detect frontal lobe disturbance. However, so far, research 
evidence has been limited and somewhat inconclusive. Method: In this retrospective 
study, performance on the TMT-B of 55 patients with known focal frontal lesions, 27 
patients with focal non-frontal lesions and 70 healthy controls was compared. 
Completion time and the number of errors made were examined. Results: Patients 
with frontal and non-frontal lesions performed significantly worse than healthy 
controls for both completion time and the number of errors. However, there was no 
significant difference for both completion time and the number of errors when 
patients with frontal and non-frontal lesions were compared. Performance was also 
not significantly different between patients with focal lesions within different regions 
of the frontal lobe.  Conclusions: Our findings suggest that the TMT-B is a robust test 
for detection of brain dysfunction. However, its capacity for localisation appears 
rather limited. Clinicians should be cautious when drawing conclusions from 
performance on the TMT-B alone.  
 
 
 
 
Keywords: frontal lobes, focal lesions, executive function, neuropsychology, 
neuropsychological tests, brain diseases 
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Introduction 
The Trail Making Test (TMT; Army Individual Test Battery, 1944) is one of the most 
widely used neuropsychological tests in the clinical setting, with Part B of the TMT 
(TMT-B) the most commonly administered subtest. It is quick and easy to administer 
and has been shown to be highly sensitive to brain dysfunction in a variety of 
neurological disorders such as Traumatic Brain Injury and Alzheimer’s Disease (e.g. 
Lange, Iverson, Zakrzewski, Ethel-King & Franzen, 2005; Rasmusson, Zonderman, 
Kawas, & Resnick, 1998). TMT-B requires subjects to connect a series of 25 
encircled numbers and letters pseudo-randomly arranged on a page in ascending 
order, alternating between number and letter (e.g. 1-a-2-b), as quickly as possible. 
Completion time is the most frequently used dependent measure for performance. 
However, assessing the number of errors made has also been suggested to be a useful 
measure (Mahurin et al., 2006; Stuss et al., 2001). Since its original conception, many 
different versions of the task have been developed to accommodate and account for 
verbal/visual difficulties, physical limitations and/or age differences (see Bowie & 
Harvey, 2006 and Spreen & Strauss, 1998). 
TMT-B is generally regarded as a test of higher-order executive function 
(Spreen & Strauss, 1998). Accurate detection of executive impairment is important 
for the clinical management of many common neurological disorders such as stroke 
and dementia. A general assumption is that poor performance on TMT-B can be used 
as a marker for frontal lobe dysfunction. Indeed, the TMT-B is often used clinically 
for identifying patients with frontal lobe disturbances compared with those with non-
frontal disturbances (e.g. Delis, Kaplan & Kramer, 2001; Ettlin et al., 2000).  
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However, research evidence so far for the specificity of the TMT-B in detecting 
frontal lobe dysfunction has been relatively limited and results have been mixed. The 
majority of studies have mainly compared the performance of patients with frontal 
lobe lesions with a healthy control group only (e.g. Davidson, Gao, Mason, Winocur, 
& Anderson, 2008; Yochim, Baldo, Nelson, & Delis, 2007).  
Few studies have directly compared performance between patients with frontal 
and non-frontal lesions. In particular, a seminal study by Stuss and colleagues (2001) 
found that patients with frontal lobe lesions were slower at completing TMT-B 
compared with healthy controls and patients with non-frontal brain pathology. Within 
the frontal lobe patient group, those with dorsolateral damage were most impaired 
while those with inferior-medial damage were least affected. This is consistent with 
fMRI findings which show greater activity in the left dorsolateral prefrontal region 
during TMT-B performance (Moll et al., 2002). Interestingly also, they noted that in 
their sample only patients with frontal lobe lesions made more than one error. Stuss 
and colleagues concluded that the TMT-B is useful for assessing frontal lobe function 
and in particular that error analysis may be a more informative measure to categorize 
performance than completion time. However, the sample of frontal patients included 
over 35% of patients with bilateral lesions as well as traumatic lesions. In contrast, the 
sample of non-frontal patients did not include bilateral or traumatic lesions, and the 
sample was relatively small (n=13). These factors may have contributed to the 
heightened difference in performance found between the two lesion groups.  
In contrast, other studies have not found a difference in performance between 
frontal and non-frontal patients on the TMT-B when comparing completion time data 
(for a meta-analysis, see Demakis, 2004). In a study by Reitan and Wolfson (1995), 
performance of four patient groups of equal size that differed in lesion location 
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(frontal vs non-frontal) and lateralization (left vs. right) on the TMT-B was compared. 
Completion time on the TMT-B was not significantly different for frontal versus non-
frontal patients or between left and right lesioned patients. Similarly, in a relatively 
large retrospective series of acute stroke patients, no significant difference in 
performance was observed between frontal and non-frontal stroke patients (Tamez, et 
al., 2011). However, neither study investigated error frequency in their analysis or 
looked at more specific neuroanatomical sub-regions within the frontal lobe (e.g. 
medial vs. dorsolateral) which Stuss and colleagues proposed as important 
discriminating factors. In addition, neither study included a healthy control group for 
comparison.  
The aim of our retrospective study was to compare performance on the TMT-
B in a large sample of patients with focal frontal and non-frontal lesions, and healthy 
controls. Importantly, both completion time and error frequency was examined for 
any differences in performance between groups.  
 
Methods 
Participants 
Patients assessed in the Neuropsychology Department of the National Hospital for 
Neurology and Neurosurgery (London, UK) were retrospectively screened for study 
eligibility. Inclusion criteria for the study were (a) the presence of a single focal lesion 
confined to the frontal or non-frontal brain region (b) availability of 
neuropsychological data which must include TMT Part B (c) aged between 18-80 
years (d) no gross perceptual disturbances (i.e. above the cut-off on the Incomplete 
Letters subtest of the VOSP), and (e) absence of psychiatric disorders or previous 
neurological disorders. A total of 82 patients with focal unilateral lesions who met the 
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inclusion criteria were identified for the study (55 frontal patients, 27 non-frontal 
patients). All diagnosis was confirmed by clinical neurological investigations 
including neuroimaging (MRI or CT). All tumour patients had undergone resection 
prior to neuropsychological assessment.  Frontal lesions were reviewed by two 
independent neurologists from available MRI (n=39; T1 weighted images on 1.5T 
scanners) and CT scans (n=16). Lesions were then classified by standard laterality 
(left: n=28, right: n=27) and by a more refined anatomical sub-division of four main 
subgroups: orbital (n=8), left lateral (n=12), right lateral (n=12) and medial (n=23). 
The procedure for classifying lesion location is described in detail elsewhere (Murphy 
et al., 2013). In addition, seventy healthy controls who had no prior history of 
neurological or psychiatric disorders were also included for comparison.  The study 
was approved by the local clinical governance and ethics committees.  Some of the 
data from these patients were gathered as part of a larger study of frontal lobe lesions 
and have been included in previous published studies (e.g. Robinson, Shallice, 
Bozzali, & Cipolotti, 2012). 
 
Neuropsychological assessment 
As this was a retrospective study, all participants were administered a series of 
cognitive tests at the time of their neurological investigation. An estimate of pre-
morbid optimal level of functioning was obtained using the National Adult Reading 
Test (NART) and the Incomplete Letters of the Visual Object and Space Perception 
(VOSP) test was used to assess visual-perceptual functioning. TMT-B was 
administered as a part of the assessment, following the standard protocol (Bowie & 
Harvey, 2006). Part A of the TMT was not administered. The two main dependent 
variables were completion time in seconds and number of errors. Completion time 
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was recorded at the time of administration and the number of errors made was 
classified and recorded retrospectively.  
 
Insert Table 1 here 
 
Statistical analyses 
For analyses of completion time data, an Analysis of Covariance (ANCOVA) was 
employed with group (frontal, non-frontal, healthy control) as the main between 
subjects factor. Age and NART scores were entered as covariates of no interest in the 
analyses given that age and intellectual functioning are known to mediate 
neuropsychological test performance. The raw completion time measure was 
transformed using a natural log transformation before analyses to deal with the 
significant skew in the data. Error data were analysed using the Chi-square test. 
Where comparisons contained cells of size less than 5, the Fisher’s exact test was 
employed. We divided participants of each group into those who did not make an 
error and those who made one or more error to assess whether one group is more 
likely to make an error than another. In view of Stuss et al.’s (2001) finding that only 
patients with frontal lobe lesions made greater than one error on the TMT, we ran an 
additional analysis dividing participants into those who made one error and those who 
made more than one error.  
We conducted three main analyses. First, we compared TMT-B performance 
for each of the two patient groups with the healthy control group separately. This 
analysis investigated whether TMT-B could distinguish individuals with brain 
impairment from those without, irrespective of lesion location.  Secondly, we 
compared performance between the two patient groups directly to examine whether 
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performance on the TMT-B is significantly different between them. Finally, we 
examined possible lateralization or localization effects in performance for patients 
with frontal lobe lesions.  
 
Results  
All groups were well-matched for age, gender and years of education (p>0.1). Table 1 
provides a summary of group demographic information. There was no apparent 
difference between the frontal and non-frontal patient groups in terms of chronicity or 
side of injury (p>0.1). The time since injury at assessment was also not significantly 
correlated with TMT-B completion time (p>0.1).  On neuropsychological assessment, 
there was no apparent difference between groups on the NART (p>0.1) or on a test of 
visual perception (VOSP, Incomplete letters, p>0.1).   
 
Comparison between frontal/non-frontal patients with healthy controls 
For completion time, both frontal (x¯=90.31s, SD=55.82) and non-frontal (x¯=96.70s, 
SD=58.25) patients were significantly slower on completing the TMT-B compared 
with healthy controls ((x¯=67.24s, SD=24.44); Frontal vs. Control – F(1,119)=11.48, 
p<0.01, ηp2= 0.09;  Non-frontal vs. Control – F(1,93)=11.48, p<0.01, ηp2= 0.11; see 
Figure 1a).  
Similarly, both frontal and non-frontal patients were significantly more likely 
to make an error than healthy controls (Frontal vs. Control - χ2 (1) = 5.07, p<0.05, Φ= 
-0.20; Non-frontal vs. Control – χ2 (1) =9.26, p<0.05, Φ= -0.31). Figure 1b shows the 
percentage of participants in each error frequency category for the three groups. As 
shown, although the majority of healthy controls made no errors (87%), 13% did 
make an error with one participant (out of the total 70) making two errors. Therefore, 
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making an error in itself does not necessarily discriminate between those with and 
without a focal lesion.  
 
Insert Figure 1 here 
 
Comparison between frontal and non-frontal patients  
Comparison between the frontal and non-frontal patient group on completion time for 
the TMT-B revealed no significant difference (F(1,76)=0.39, p=0.53). In addition to 
conventional null-hypothesis significance testing, we also subjected completion time 
data to Bayesian analysis which is thought to be able to provide evidence in support 
of the null-hypothesis (Gallistel, 2009); in this instance, that completion time 
performance for the two patient groups are equivalent. Analyses yielded odds of 31:1 
(weight: 1.50) in favour of the null-hypothesis. These odds are considered strong and 
weights are considered heavy (c.f. Gallistel, 2009).   
In regards to errors, there was no significant difference between the frontal 
and non-frontal groups in the likelihood of making an error and making no errors (χ2 
(1) =1.11, p=0.29). Furthermore, there was also no difference when we compared the 
likelihood of these two groups in making one or more than one error (p=1.00). In our 
sample, five patients in the frontal group (8%) and four patients in the non-frontal 
group (15%) made more than one error.  
 
Comparison between lesion locations for frontal patients 
To examine whether lesion location within the frontal lobe had an effect on 
performance on the TMT-B, frontal patients were divided into separate subgroups 
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based on standard lesion lateralization (left, right) and by more specific 
neuroanatomical sub-regions (orbital, left lateral, right lateral, medial).  
Comparison of completion time for the TMT-B between left (x¯=89.47s, 
SD=30.34) and right (x¯=91.25s, SD=70.78) frontal patients revealed no significant 
difference between groups (F(1,49)=0.01, p=0.36). Similarly, no significant 
difference was found between the different sub-regions (orbital: x¯=81.73s, SD=39.77; 
left lateral: x¯=93.91s, SD=47.00; right lateral: x¯= 102.86s, SD=91.90; medial: x¯
=85.95s, SD=46.67; F(3,47)=0.67, p=0.58). There was also no significant difference 
in the likelihood of making an error between the left and right frontal patients (χ2 (1) 
=0.26, p=0.61) or between the different sub-regions (p=0.88).  
We also ran an additional analysis to compare patients with lateral versus 
medial frontal lesions by combining the patients with left and right lateral lesions into 
one group. This did not alter the pattern of results.  
 
Discussion 
 
Our findings show that the TMT-B is a reliable test for detecting brain impairment. 
Both patients with frontal and non-frontal lobe lesions performed worse than the 
neurologically intact participants in regards to both efficiency and accuracy. Critically 
however, completion time performance on the TMT-B was not significantly different 
between the two patient groups.  The presence or number of errors performed during 
the task did not appear to provide any additional information. Non-frontal patients 
were equally likely to make an error or more than one error on the task compared with 
frontal patients. Furthermore, a small proportion of neurologically intact participants 
also made an error on the task. These results do not corroborate with that of Stuss and 
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colleagues (2001) who suggested that error analysis could distinguish frontal from 
non-frontal lesions. This could be due to the different composition of patient groups 
between the two studies; the frontal patient group in the previous study contained a 
large proportion of patients with bilateral lesions. Our study corroborates with 
previous studies that have shown no difference in performance between frontal and 
non-frontal patients in TMT-B efficiency (Demakis, 2004; Reitan & Harvey, 1995; 
Tamez et al., 2011) and extends this by demonstrating a lack of effect similarly when 
examining the number of errors made.   
 We also found that TMT-B performance could not distinguish between 
different frontal lesion locations. Contrary to previous suggestions that TMT-B 
performance might be left lateralized (e.g. Moll et al., 2002) or localized to the 
dorsolateral region (e.g. Stuss et al., 2001), we found no significant differences in 
performance between patients with left and right frontal lesions or between patients 
with dorsolateral lesions compared with medial or orbital lesions. Our findings 
suggest that TMT-B performance does not depend on any specific frontal region.  
Although our findings show that TMT-B performance cannot distinguish 
patients with frontal and non-frontal focal lesions, or between different sub-regions of 
the frontal lobe, we are not suggesting that the TMT is a task that does not require 
frontal lobe involvement. Rather, we suggest that performance on the TMT-B most 
likely relies on a distributed network involving both frontal and non-frontal regions.  
Functional imaging has been one useful way of elucidating underlying brain networks 
involved in performing the TMT-B, although translation of the task into a design 
optimised for imaging has its limitations. Nevertheless, recent studies have 
consistently shown that successful performance on the TMT-B involves not only 
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frontal regions, but also posterior and subcortical regions (Jacobson, Blanchard, 
Connolly, Cannon & Garavan, 2011; Zakzanis, Mraz & Graham, 2005).  
From a clinical perspective, the TMT-B can offer many insights regarding a 
patient’s cognitive abilities.  However, our findings suggest it may have limited utility 
as a tool in detecting executive dysfunction specifically as task performance most 
likely depends upon a range of cognitive processes, some of which require non-frontal 
brain regions. As such, caution should be used when drawing conclusions from TMT-
B performance alone. Further work is needed to establish whether current findings 
also extend to the various alternate versions of the task (e.g. Oral or Colour TMT).   
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Table 1 
Demographic and Neuropsychological Data: Patients and Healthy Controls  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Note: Despite absolute differences in means, no statistical difference was found 
between groups for all demographic and neuropsychological variables.  
 
 
 
 
 
 
 
 
 N Mean (SD) 
Age (Years)   
Frontal patients 55 46.45 (14.10) 
Non-frontal patients 27 45.33 (14.99) 
Healthy Controls 70 48.44 (14.50) 
Gender (M/F)   
Frontal patients 30/25 (55%/45%) 
Non-frontal patients 14/13 (52%/48%) 
Healthy Controls 39/31 (56%/44%) 
Education (Years)   
Frontal patients 46 13.43 (3.00) 
Non-frontal patients 26 14.62 (3.44) 
Healthy Controls 52 13.87 (3.03) 
Side of injury (Left/Right)    
Frontal patients 28/27 (51%/49%) 
Non-frontal patients 18/9 (67%/33%) 
Chronicity (Months)    
Frontal patients 54 15.86 (26.55) 
Non-frontal patients 27 12.11 (22.51) 
Aetiology  (Low Grade 
Tumour/Cerebrovascular 
Accident/Meningioma) 
  
Frontal patients  22/18/15 (40%/33%/27%) 
      Non-frontal patients  14/9/4 (52%/33%/15%) 
   
Full Scale IQ (NART)   
Frontal patients 53 108.72 (11.13) 
Non-frontal patients 27 105.78 (12.06) 
Healthy Controls 70 110.50 (9.76) 
VOSP Incomplete Letters    
Frontal patients 54 19.57 (0.60) 
Non-frontal patients 14 19.50 (0.94) 
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Figure 1. Performance on the TMT-B for patients and healthy controls. (a) Mean 
completion time in seconds and 95% C.I., and (b) the number of errors. 
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